Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 40/100

Failure Rate

13.3%

83 terminated/withdrawn out of 626 trials

Success Rate

86.4%

-0.1% vs industry average

Late-Stage Pipeline

41%

255 trials in Phase 3/4

Results Transparency

23%

119 of 528 completed trials have results

Key Signals

1 recruiting119 with results63 terminated20 withdrawn

Enrollment Performance

Analytics

Phase 1
195(35.3%)
Phase 3
157(28.4%)
Phase 4
98(17.7%)
Phase 2
83(15.0%)
N/A
20(3.6%)
553Total
Phase 1(195)
Phase 3(157)
Phase 4(98)
Phase 2(83)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (626)

Showing 20 of 626 trials
NCT00522184Phase 3Completed

Intra-articular Injection of Etanercept in Patient Suffering From Rheumatoid Arthritis : a Double-blind Randomized Study

Role: collaborator

NCT00563524Phase 1Completed

Study Evaluating The Safety And Tolerability Of ILV-094 In Subjects With Psoriasis

Role: lead

NCT00200902Phase 4Completed

Evaluation of Depression Symptoms and Brain Activity Associated With Response to Treatment of Depression

Role: collaborator

NCT01134575Phase 2Completed

CMC-544 in Relapsed Refractory Acute Lymphoblastic Leukemia (ALL)

Role: collaborator

NCT00838955Phase 2Terminated

Temsirolimus for Relapsed/Refractory Hodgkin's Lymphoma

Role: collaborator

NCT01038505Phase 4Withdrawn

Comparison of Tacrolimus and Myfortic Versus Tacrolimus and Sirolimus

Role: collaborator

NCT00406640Phase 3Completed

Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) vs. Escitalopram in Postmenopausal Women

Role: lead

NCT00393471Phase 3Completed

Study Comparing Etanercept Plus Methotrexate to Either Etanercept or Methotrexate Alone in Rheumatoid Arthritis.

Role: lead

NCT00518375Phase 4Completed

Study Comparing Graft Function in Renal Allograft Recepients Receiving Reduced or Standard Dose CsA With Sirolimus

Role: lead

NCT00519116Phase 4Completed

Study Comparing Standard Dose and Reduced Dose Tacrolimus With Sirolimus in Renal Transplant Patients

Role: lead

NCT00195429Phase 4Completed

A Study Comparing the Withdrawal of Steroids or Tacrolimus in Kidney Transplant Recipients

Role: lead

NCT01050218Phase 3Terminated

Study Evaluating the Long-Term Safety of Desvenlafaxine Succinate Sustained-Release (DVS SR) in Subjects With Pain Associated With Diabetic Peripheral Neuropathy

Role: lead

NCT00571792Terminated

Evaluation of Airway Gene Expression in COPD and Controlled Populations

Role: collaborator

NCT00593060Phase 1Completed

Temsirolimus (CCI-770, Torisel) Combined With Cetuximab in Cetuximab-Refractory Colorectal Cancer

Role: collaborator

NCT00293215Phase 1Terminated

Biodistribution Study of CMD-193 in Patients With Advanced Tumours Expressing the Lewis-Y Antigen

Role: collaborator

NCT00688870Phase 3Completed

Study Evaluating A 13-Valent Pneumococcal Conjugate Vaccine Administered to Infants in Taiwan

Role: lead

NCT00759655Phase 3Terminated

Study Evaluating The Efficacy And Safety Of Xyntha In Children Less Than 6 Years Of Age

Role: lead

NCT00783536Phase 4Withdrawn

A Multicenter Study to Compare the Efficacy and Safety of the Combination of Etanercept and Methotrexate in Treatment of Rheumatoid Arthritis

Role: lead

NCT00151398Phase 2Completed

Study Evaluating Lecozotan SR in Mild to Moderate Alzheimer's Disease (AD)

Role: lead

NCT00124891Phase 2Terminated

Study Evaluating GAP-486 in Non-sustained Ventricular Tachycardia

Role: lead